3 Stocks Pushing The Health Services Industry Downward - TheStreet

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

One out of the three major indices are trading up today with the

Dow Jones Industrial Average

(

^DJI

) trading up 12 points (0.1%) at 17,830 as of Tuesday, Nov. 25, 2014, 12:15 PM ET. The NYSE advances/declines ratio sits at 1,420 issues advancing vs. 1,510 declining with 216 unchanged.

The Health Services industry currently sits down 0.2% versus the S&P 500, which is unchanged.

TheStreet would like to highlight 3 stocks pushing the industry lower today:

3.

Cigna

(

CI

) is one of the companies pushing the Health Services industry lower today. As of noon trading, Cigna is down $0.43 (-0.4%) to $101.97 on light volume. Thus far, 496,805 shares of Cigna exchanged hands as compared to its average daily volume of 1.6 million shares. The stock has ranged in price between $101.13-$102.60 after having opened the day at $102.49 as compared to the previous trading day's close of $102.40.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Cigna Corporation, a health services organization, provides insurance and related products and services in the United States and internationally. Cigna has a market cap of $26.7 billion and is part of the health care sector. Shares are up 17.1% year-to-date as of the close of trading on Monday. Currently there are 8 analysts that rate Cigna a buy, no analysts rate it a sell, and 7 rate it a hold.

TheStreet Ratings rates

Cigna

as a

buy

. The company's strengths can be seen in multiple areas, such as its solid stock price performance, revenue growth, largely solid financial position with reasonable debt levels by most measures, notable return on equity and growth in earnings per share. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full

Cigna Ratings Report

now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

2. As of noon trading,

Boston Scientific

(

BSX

) is down $0.32 (-2.4%) to $12.82 on light volume. Thus far, 4.3 million shares of Boston Scientific exchanged hands as compared to its average daily volume of 13.5 million shares. The stock has ranged in price between $12.81-$13.22 after having opened the day at $13.11 as compared to the previous trading day's close of $13.14.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. The company operates in three segments: Cardiovascular, Rhythm Management, and MedSurg. Boston Scientific has a market cap of $17.2 billion and is part of the health care sector. Shares are up 9.3% year-to-date as of the close of trading on Monday. Currently there are 12 analysts that rate Boston Scientific a buy, no analysts rate it a sell, and 11 rate it a hold.

TheStreet Ratings rates

Boston Scientific

as a

hold

. The company's strengths can be seen in multiple areas, such as its compelling growth in net income, revenue growth and good cash flow from operations. However, as a counter to these strengths, we find that the company has favored debt over equity in the management of its balance sheet. Get the full

Boston Scientific Ratings Report

now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

1. As of noon trading,

CVS Health

(

CVS

) is down $0.54 (-0.6%) to $90.32 on light volume. Thus far, 1.2 million shares of CVS Health exchanged hands as compared to its average daily volume of 4.4 million shares. The stock has ranged in price between $90.13-$91.08 after having opened the day at $90.72 as compared to the previous trading day's close of $90.87.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

CVS Health Corporation, together with its subsidiaries, provides integrated pharmacy health care services in the United States. The company operates through Pharmacy Services and Retail Pharmacy segments. CVS Health has a market cap of $102.4 billion and is part of the health care sector. Shares are up 27.0% year-to-date as of the close of trading on Monday. Currently there are 16 analysts that rate CVS Health a buy, no analysts rate it a sell, and 3 rate it a hold.

TheStreet Ratings rates

CVS Health

as a

buy

. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance, largely solid financial position with reasonable debt levels by most measures and notable return on equity. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full

CVS Health Ratings Report

now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

If you are interested in one of these 3 stocks, ETFs may be of interest. Investors who are bullish on the health services industry could consider

Health Care Select Sector SPDR

(

XLV

) while those bearish on the health services industry could consider

ProShares Ultra Short Health Care

(

RXD

).

null